Searched for
ANAEMIA TREATMENT DRUG
Why are Indians suddenly buying more vitamins after starting Ozempic-like weight loss drugs?Demand for vitamin and nutritional supplements is surging in India. This trend follows the increased availability of semaglutide-based weig...- Glenmark to launch generic medication in USGlenmark Pharmaceuticals will launch a new generic medication in the United States this month. This drug treats anaemia. It also prevents s...
- CCI lacks power to examine disputes over patented products, says NCLATThe National Company Law Appellate Tribunal has ruled that the Competition Commission of India cannot investigate patent disputes. The trib...
- What your hair reveals about your kidney health: Hidden signs of nutrient deficiencies, toxins, and chronic kidney diseaseKidney disease can cause significant hair loss. Waste buildup and nutrient imbalances weaken hair follicles. Patients may experience thinni...
- Govt announces Rs 10-crore prize for new drug to treat sickle cell diseaseThe government is awarding Rs 10 crore to develop a sickle cell disease drug. This initiative addresses the disproportionate impact on trib...
- Gene therapy for blood cancer shows 73 per cent response rate in clinical trialsResearchers, including those from the Indian Institute of Technology-Bombay and Tata Memorial Hospital, Mumbai, said in low and middle-inco...
- Medicines for four rare diseases become cheaper due to domestic productionDrugs for four of these diseases -Tyrosinemia Type 1, Gaucher's Disease, Wilson's Disease and Dravet-Lennox Gastaut Syndrome - along with s...
- Zydus gets DCGI nod for drug to treat anaemia associated with chronic kidney diseaseZydus Lifesciences on Monday said it has received an approval from the Drug Controller General of India (DCGI) for Oxemia (Desidustat), a f...
- Cadila Healthcare Q3 Results: Firm posts 5% decline in profit at Rs 500 crConsolidated total revenue from operations stood at Rs 3,655 crore during the quarter under review as compared to Rs 3,633 crore in the yea...
- Zydus Cadila seeks DCGI approval for novel oral pill to treat anaemia in kidney patientsThe pill technically called hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitor can be given to both patients who are on dialysi...
- Abbott introduces single-dose formulation of carbetocin in IndiaPPH, if left untreated, can result in complications like anaemia in the postpartum period or aggravate mental health problems including pos...
- Sun Pharma, US-based Rockwell Medical enter into licensing pact for Triferic in IndiaAs per the terms of the agreement, Sun Pharma will be the exclusive development and commercialisation partner for Triferic during the term ...
- Use compulsory license and put ceiling to curb prices of patented medicines: Government panelThe committee noted that the prices of patented anti-cancer and antifungal drugs are "on the higher side" and cited the example of Rs 1 lak...
- Zydus starts phase II trials of molecule targeting anaemiaAnaemia commonly arises in kidney disease patients, because the kidneys no longer produce sufficient amounts of erythropoietin, a hormone w...
- Vitamin B12 deficiency may lead to major neurological problemsVitamin B12 deficiency causes anaemia and subacute combined degeneration of the spinal cord, which leads to destruction and can present as ...
- Hetero launches biosimilar Rituximab in IndiaHyderabad based Hetero pharma has launched biosimilar drug Rituximab under the brand name of MABALL, used in the treatment of blood cancer.
- IIT Madras sets target to kill only cancer cellsThe team has created a class of molecules called immunotoxins to specifically target cancer cells, while leaving healthy cells unaffected.
- Cipla partners with Hetero to launch biosimilar anaemia drugActorise is a biosimilar of 'Darbepoetin alfa', which is marketed by US-based Amgen under the brand Aranesp.
- Rel Life Sciences to focus on R&D, for nowThe company is all set to launch fifth biosimilar drug and seeks approvals for clinical trials and stem-cell treatment.
- Roche files for Avastin to treat breast cancer in EuropeSwiss drugmaker Roche has filed its Avastin drug for use in previously untreated advanced breast cancer in Europe, the company said on Mond...
Load More
